Topic

Oxervate (cenegermin)

A collection of 4 issues

Get Oxervate (Cenegermin) Covered by Cigna in New York: Prior Authorization Guide, Appeals Process & Alternative Treatments

Answer Box: Getting Oxervate (Cenegermin) Covered by Cigna in New York Oxervate (cenegermin) requires prior authorization from Cigna and typically involves step therapy with alternatives like preservative-free artificial tears and autologous serum drops first. If denied, you have 180 days for internal appeals and can request external review through New
6 min read

Coding That Helps Get Oxervate (cenegermin) Approved by UnitedHealthcare in California: ICD-10, HCPCS, and NDC Guide

Answer Box: Getting Oxervate Covered by UnitedHealthcare in California Oxervate (cenegermin) requires prior authorization from UnitedHealthcare with specific coding requirements. Use ICD-10 codes H16.231-H16.233 for stage 2/3 neurotrophic keratitis, HCPCS code J3590, and NDC 71923-019-01. Submit through OptumRx with documented artificial tear failure and ophthalmologist prescription. If
6 min read

How to Get Oxervate (cenegermin) Covered by Humana in Pennsylvania: Appeals Guide and Medical Necessity Templates

Quick Answer: Getting Oxervate Covered by Humana in Pennsylvania Oxervate (cenegermin) requires prior authorization from Humana for stage 2-3 neurotrophic keratitis. The fastest path: your ophthalmologist submits a medical necessity letter documenting failed conventional treatments (lubricants, bandage lenses) and confirmed corneal sensation loss. If denied, you have 65 days to
6 min read